JP2003527414A - C型肝炎を治療するための薬剤 - Google Patents
C型肝炎を治療するための薬剤Info
- Publication number
- JP2003527414A JP2003527414A JP2001568401A JP2001568401A JP2003527414A JP 2003527414 A JP2003527414 A JP 2003527414A JP 2001568401 A JP2001568401 A JP 2001568401A JP 2001568401 A JP2001568401 A JP 2001568401A JP 2003527414 A JP2003527414 A JP 2003527414A
- Authority
- JP
- Japan
- Prior art keywords
- ukrain
- patients
- ifn
- hepatitis
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0048100A AT408719B (de) | 2000-03-22 | 2000-03-22 | Mittel zur behandlung von hepatitis c |
AT481/2000 | 2000-03-22 | ||
PCT/AT2001/000076 WO2001070203A2 (de) | 2000-03-22 | 2001-03-20 | Mittel zur behandlung von hepatitis c, enthaltend ukrain |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2003527414A true JP2003527414A (ja) | 2003-09-16 |
Family
ID=3674939
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2001568401A Pending JP2003527414A (ja) | 2000-03-22 | 2001-03-20 | C型肝炎を治療するための薬剤 |
Country Status (17)
Country | Link |
---|---|
JP (1) | JP2003527414A (zh) |
KR (1) | KR20020087045A (zh) |
CN (1) | CN1416347A (zh) |
AT (1) | AT408719B (zh) |
AU (1) | AU2001239000A1 (zh) |
BG (1) | BG107088A (zh) |
BR (1) | BR0107211A (zh) |
CA (1) | CA2389173A1 (zh) |
EA (1) | EA200200584A1 (zh) |
HR (1) | HRP20020367A2 (zh) |
IL (1) | IL149314A0 (zh) |
IS (1) | IS6360A (zh) |
MA (1) | MA25509A1 (zh) |
MX (1) | MXPA02004993A (zh) |
NO (1) | NO20022253D0 (zh) |
PL (1) | PL365000A1 (zh) |
WO (1) | WO2001070203A2 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106343303A (zh) * | 2015-07-13 | 2017-01-25 | 张如安 | 灭杀乙肝病毒的饮料 |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH695417A5 (de) * | 2001-11-15 | 2006-05-15 | Ddr Wassyl Nowicky Dipl Ing | Verfahren zur Umsetzung von Alkaloiden. |
EP1459753A1 (en) | 2003-03-18 | 2004-09-22 | Nowicky, Wassyl, Dipl.-Ing. DDr. | Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in the manufacture of medicaments |
WO2008039179A1 (en) * | 2006-09-26 | 2008-04-03 | Addiction Research Institute, Inc. | Compositions for the treatment of hepatitis c and methods for using compositions for the treatment of hepatitis c |
CN106109538A (zh) * | 2016-07-29 | 2016-11-16 | 桂林淮安天然保健品开发有限公司 | 治疗丙肝的药物组合物 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3128018A1 (de) * | 1981-07-13 | 1983-04-07 | Wassyl 1060 Wien Nowicky | "verfahren zum diagnostizieren und fuer die therapeutische behandlung von tumoren und/oder infektioesen krankheiten verschiedenster art unter praeparativem einsatz von alkaloid-verbindungen bzw. deren salze" |
US4970212A (en) * | 1982-05-18 | 1990-11-13 | Nowicky Wassili | Method of treating human illnesses which compromise the ability to mount an effective immunological response |
US4816462A (en) * | 1982-05-18 | 1989-03-28 | Nowicky Wassili | Method for diagnosing and for the therapeutic treatment of tumors and/or infectious diseases of different types with alkaloid-compounds |
PT93772A (pt) * | 1989-04-17 | 1991-01-08 | Searle & Co | Processo para a preparacao de composicoes para o tratamento de neoplasias, contendo um agente anti-neoplastico, por exemplo doxorubicina e um agente protector para reduzir os efeitos secundarios, por exemplo carbetimer |
-
2000
- 2000-03-22 AT AT0048100A patent/AT408719B/de not_active IP Right Cessation
-
2001
- 2001-03-20 CA CA002389173A patent/CA2389173A1/en not_active Abandoned
- 2001-03-20 WO PCT/AT2001/000076 patent/WO2001070203A2/de active Application Filing
- 2001-03-20 BR BR0107211-0A patent/BR0107211A/pt not_active IP Right Cessation
- 2001-03-20 PL PL01365000A patent/PL365000A1/xx not_active Application Discontinuation
- 2001-03-20 JP JP2001568401A patent/JP2003527414A/ja active Pending
- 2001-03-20 AU AU2001239000A patent/AU2001239000A1/en not_active Abandoned
- 2001-03-20 IL IL14931401A patent/IL149314A0/xx unknown
- 2001-03-20 EA EA200200584A patent/EA200200584A1/ru unknown
- 2001-03-20 CN CN01803046A patent/CN1416347A/zh active Pending
- 2001-03-20 KR KR1020027005739A patent/KR20020087045A/ko not_active Application Discontinuation
- 2001-03-20 MX MXPA02004993A patent/MXPA02004993A/es unknown
-
2002
- 2002-04-24 IS IS6360A patent/IS6360A/is unknown
- 2002-04-26 HR HR20020367A patent/HRP20020367A2/hr not_active Application Discontinuation
- 2002-05-10 NO NO20022253A patent/NO20022253D0/no unknown
- 2002-05-28 MA MA26657A patent/MA25509A1/fr unknown
- 2002-09-12 BG BG107088A patent/BG107088A/xx unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106343303A (zh) * | 2015-07-13 | 2017-01-25 | 张如安 | 灭杀乙肝病毒的饮料 |
Also Published As
Publication number | Publication date |
---|---|
PL365000A1 (en) | 2004-12-27 |
MXPA02004993A (es) | 2003-10-14 |
IS6360A (is) | 2002-04-24 |
WO2001070203A2 (de) | 2001-09-27 |
KR20020087045A (ko) | 2002-11-21 |
ATA4812000A (de) | 2001-07-15 |
NO20022253L (no) | 2002-05-10 |
WO2001070203A3 (de) | 2002-09-06 |
HRP20020367A2 (en) | 2004-02-29 |
IL149314A0 (en) | 2002-11-10 |
AU2001239000A1 (en) | 2001-10-03 |
MA25509A1 (fr) | 2002-07-01 |
NO20022253D0 (no) | 2002-05-10 |
BG107088A (en) | 2003-05-30 |
AT408719B (de) | 2002-02-25 |
EA200200584A1 (ru) | 2003-06-26 |
BR0107211A (pt) | 2004-01-06 |
CN1416347A (zh) | 2003-05-07 |
CA2389173A1 (en) | 2001-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU750026B2 (en) | Product comprising at least a double stranded RNA combined with at least an antiviral agent | |
JP5539363B2 (ja) | インターフェロンおよびリバビリンとのhcvns3プロテアーゼ阻害剤の組合せ | |
JP2009502920A5 (zh) | ||
JP2002539244A (ja) | 成長促進用組成物 | |
JP2010070566A (ja) | ウイルス性肝炎の処置 | |
JP2000507917A (ja) | 持続的低用量サイトカイン注入治療 | |
KR20050055053A (ko) | 만성 C형 간염을 치료하기 위한 폴리에틸렌글리콜-인터페론-α 및 리바비린의 용도 | |
JP2009522371A5 (zh) | ||
US20100266590A1 (en) | Combination therapy | |
JP2018531945A (ja) | 免疫系を刺激するためのペプチドの使用 | |
TW201138773A (en) | Dosage regimens for HCV combination therapy | |
JP2002527522A (ja) | 慢性C型肝炎感染を有する患者における検出可能HCV−RNA根絶用リバビリン−インターフェロン−α併用療法 | |
JP2007262082A (ja) | 多発性硬化症の処置のためのリルゾールの使用 | |
JP2003527414A (ja) | C型肝炎を治療するための薬剤 | |
JP2003507339A (ja) | PEG−IFN−αと共同させたミコフェノラートモフェチル | |
AU2021271862A1 (en) | TLR7/8 antagonists for the treatment of coronavirus infections | |
JP2002525333A (ja) | ラミブジンまたはラミブジンおよびファンシクロビルと組み合わせたチモシン−アルファ1によるb型肝炎ウィルスの治療 | |
JP2003503457A (ja) | 心臓血管合併症の治療用薬剤の製造におけるアンギオテンシンii1型受容体アンタゴニストの使用 | |
JP2003522121A (ja) | 多発性硬化症の処置のためのリルゾールの使用 | |
JP2003519088A (ja) | Hiv感染患者の治療および予防のためのgssgレダクターゼの使用 | |
JP2000007578A (ja) | C型肝炎ウイルスの陰性化のための投薬システム | |
WO2002011736A1 (en) | Naadp analogues for modulating t-cell activity | |
US7728033B2 (en) | Mycophenolate mofetil in diabetic nephropathy | |
IE921208A1 (en) | Complexes of polyadenylic acid with polyuridylic acid | |
WO1991004047A1 (en) | Synergistic effect of human recombinant interferon-beta on halogenated pyrimidines |